3.10
price down icon3.43%   -0.11
after-market Handel nachbörslich: 3.10
loading
Schlusskurs vom Vortag:
$3.21
Offen:
$3.12
24-Stunden-Volumen:
126.19K
Relative Volume:
0.37
Marktkapitalisierung:
$26.27M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-0.64%
1M Leistung:
-10.40%
6M Leistung:
-49.51%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$3.02
$3.25
1-Wochen-Bereich:
Value
$2.761
$3.355
52-Wochen-Spanne:
Value
$2.761
$16.12

Hyperion Defi Inc Stock (HYPD) Company Profile

Name
Firmenname
Hyperion Defi Inc
Name
Telefon
833-393-6684
Name
Adresse
295 MADISON AVENUE, NEW YORK
Name
Mitarbeiter
57
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
HYPD's Discussions on Twitter

Compare HYPD vs VRTX, REGN, ARGX, ALNY, ONC

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
HYPD
Hyperion Defi Inc
3.10 27.20M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.82 121.40B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
764.93 83.25B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
728.11 46.39B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.51 43.41B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
292.94 33.09B 5.36B 287.73M 924.18M 2.5229

Hyperion Defi Inc Stock (HYPD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-12-24 Eingeleitet Chardan Capital Markets Buy
2025-12-16 Eingeleitet Cantor Fitzgerald Overweight
2024-11-18 Herabstufung H.C. Wainwright Buy → Neutral
2021-03-01 Eingeleitet Northland Capital Outperform
2020-02-03 Herabstufung Oppenheimer Outperform → Perform

Hyperion Defi Inc Aktie (HYPD) Neueste Nachrichten

pulisher
Mar 03, 2026

Avanza Pension reports 10.19% stake in Hyperion DeFi (NASDAQ: HYPD) - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

HYPD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 03, 2026
pulisher
Mar 02, 2026

Hyperion DeFi leadership outlines conviction in next-generation financial infrastructure at NASDAQ - Traders Union

Mar 02, 2026
pulisher
Mar 02, 2026

HYPD Technical Analysis & ETF Price Forecast - Intellectia AI

Mar 02, 2026
pulisher
Feb 27, 2026

HYPD Should I Buy - Intellectia AI

Feb 27, 2026
pulisher
Feb 18, 2026

MSN Money - MSN

Feb 18, 2026
pulisher
Feb 07, 2026

Hyperion to expand options income using HYPE as collateral - 디지털투데이

Feb 07, 2026
pulisher
Feb 05, 2026

Hyperion DeFi - Nasdaq

Feb 05, 2026
pulisher
Feb 04, 2026

Hyperion DeFi launches institutional yield vault on Hyperliquid By Investing.com - Investing.com Nigeria

Feb 04, 2026
pulisher
Feb 04, 2026

Hyperliquid treasury seeks revenue boost using HYPE holdings as options collateral - The Block

Feb 04, 2026
pulisher
Feb 04, 2026

Hyperion DeFi launches institutional yield vault on Hyperliquid - Investing.com

Feb 04, 2026
pulisher
Feb 04, 2026

Hyperion DeFi Announces Institutional Volatility Income Vault Built on Rysk Protocol - The Manila Times

Feb 04, 2026
pulisher
Feb 04, 2026

Hyperion Defi, Inc. Announces Institutional Volatility Income Vault Built on Rysk Protocol - marketscreener.com

Feb 04, 2026
pulisher
Jan 28, 2026

Hyperliquid roars past XRP, BNB with 65% rally: Why treasury companies buy the HYPE - MSN

Jan 28, 2026
pulisher
Jan 28, 2026

Hyperliquid Roars Past XRP, BNB With 65% Rally: Why Treasury Companies Buy The HYPE - Benzinga

Jan 28, 2026
pulisher
Jan 13, 2026

Hyperion DeFi (HYPD) Price Target Increased by 46.87% to 5.99 - Nasdaq

Jan 13, 2026
pulisher
Jan 12, 2026

Hyperion DeFi Issues Letter to Shareholders - The Manila Times

Jan 12, 2026
pulisher
Jan 12, 2026

Inside the first U.S. public company built around Hyperliquid DeFi - Stock Titan

Jan 12, 2026
pulisher
Jan 09, 2026

Humacyte (NASDAQ:HUMAW) & Hyperion DeFi (NASDAQ:HYPD) Head to Head Analysis - Defense World

Jan 09, 2026
pulisher
Jan 06, 2026

Hyperion DeFi appoints Hyunsu Jung as CEO in leadership overhaul By Investing.com - Investing.com Nigeria

Jan 06, 2026
pulisher
Jan 06, 2026

Hyperion DeFi (NASDAQ:HYPD) CFO David Knox Acquires 27,950 Shares of Stock - Defense World

Jan 06, 2026
pulisher
Jan 05, 2026

Hyperion DeFi Finalizes Leadership Team and Equity Conversion - TipRanks

Jan 05, 2026
pulisher
Jan 05, 2026

Hyperion Defi, Inc. Appoints Robert Rubenstein as General Counsel, Effective January 6, 2026 - marketscreener.com

Jan 05, 2026
pulisher
Jan 05, 2026

Hyperion DeFi appoints Hyunsu Jung as CEO to fully implement its 2026 strategic plan - Bitget

Jan 05, 2026
pulisher
Jan 05, 2026

Hyperion DeFi appoints Hyunsu Jung as chief executive officer - marketscreener.com

Jan 05, 2026
pulisher
Jan 05, 2026

Hyperion Defi Appoints Hyunsu Jung As Chief Executive Officer - TradingView — Track All Markets

Jan 05, 2026
pulisher
Jan 05, 2026

Hyperion DeFi, Inc. Stock (HYPD) Opinions on New CEO Appointment and Stock Surge - Quiver Quantitative

Jan 05, 2026
pulisher
Jan 05, 2026

Hyperion DeFi appoints Hyunsu Jung as CEO in leadership overhaul - Investing.com

Jan 05, 2026
pulisher
Jan 05, 2026

Hyperion DeFi Appoints Hyunsu Jung as Chief Executive Officer - The Manila Times

Jan 05, 2026
pulisher
Jan 05, 2026

DeFi firm Hyperion taps new CEO and top lawyer for 2026 digital asset plans - Stock Titan

Jan 05, 2026
pulisher
Jan 03, 2026

Brokerages Set Hyperion DeFi, Inc. (NASDAQ:HYPD) Target Price at $4.58 - Defense World

Jan 03, 2026
pulisher
Jan 01, 2026

Hyperion DeFi (NASDAQ:HYPD) Upgraded at Zacks Research - Defense World

Jan 01, 2026
pulisher
Dec 31, 2025

Top Hyperion DeFi Insider Quietly Makes a Bold Move in the Market - TipRanks

Dec 31, 2025
pulisher
Dec 26, 2025

Hyperion DeFi (NASDAQ:HYPD) Coverage Initiated at Chardan Capital - Defense World

Dec 26, 2025
pulisher
Dec 25, 2025

HYPD Forecast — Price Target — Prediction for 2026 - TradingView — Track All Markets

Dec 25, 2025
pulisher
Dec 25, 2025

Hyperion DeFi (HYPD) Gets a Buy from Chardan Capital - The Globe and Mail

Dec 25, 2025
pulisher
Dec 24, 2025

This Hyperion DeFi Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Wednesday - Benzinga

Dec 24, 2025
pulisher
Dec 24, 2025

HYPD Analyst Forecasts - Quiver Quantitative

Dec 24, 2025
pulisher
Dec 24, 2025

Chardan Capital initiates Hyperion DeFi stock with Buy rating, $7.75 target - Investing.com Australia

Dec 24, 2025
pulisher
Dec 24, 2025

Chardan Capital Initiates Coverage of Hyperion DeFi (HYPD) with Buy Recommendation - Nasdaq

Dec 24, 2025
pulisher
Dec 24, 2025

HYPD: Chardan Capital Initiates Coverage with 'Buy' Rating | HYP - GuruFocus

Dec 24, 2025
pulisher
Dec 24, 2025

Chardan Initiates Hyperion DeFi at Buy With $7.75 Price Target - marketscreener.com

Dec 24, 2025
pulisher
Dec 23, 2025

Strahlman buys Hyperion DeFi (HYPD) shares worth $120,663 By Investing.com - Investing.com Australia

Dec 23, 2025
pulisher
Dec 23, 2025

Hyperion DeFi shares edge higher following Kinetiq airdrop and new partnership activity - MSN

Dec 23, 2025
pulisher
Dec 22, 2025

Strahlman buys Hyperion DeFi (HYPD) shares worth $120,663 - Investing.com

Dec 22, 2025

Finanzdaten der Hyperion Defi Inc-Aktie (HYPD)

Es liegen keine Finanzdaten für Hyperion Defi Inc (HYPD) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Hyperion Defi Inc-Aktie (HYPD) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Strahlman Ellen R
Director
Dec 29 '25
Buy
3.60
12,112
43,603
91,161
Strahlman Ellen R
Director
Dec 29 '25
Buy
3.61
11,856
42,800
34,869
Strahlman Ellen R
Director
Dec 26 '25
Buy
3.86
3,601
13,911
79,049
Strahlman Ellen R
Director
Dec 26 '25
Buy
3.86
3,311
12,777
23,013
Strahlman Ellen R
Director
Dec 18 '25
Buy
3.14
19,702
61,835
95,150
Strahlman Ellen R
Director
Dec 18 '25
Buy
3.14
18,742
58,829
75,448
Walters Happy David
Director
Dec 17 '25
Buy
3.02
61,930
187,152
111,930
GELTZEILER MICHAEL S
Director
Dec 17 '25
Buy
3.01
30,000
90,210
88,015
$45.68
price down icon 3.69%
$53.83
price down icon 6.87%
$29.72
price up icon 0.68%
$101.95
price down icon 1.78%
$143.57
price down icon 4.21%
biotechnology ONC
$292.94
price down icon 2.03%
Kapitalisierung:     |  Volumen (24h):